[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352497-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-352497-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","a-small-molecule-inhibitor-of-arf-gtpase-protein-1-limits-liver-and-colon-cancer-cell-growth-and-metastasis","A small molecule inhibitor of ARF GTPase protein 1 limits liver and colon cancer cell growth and metastasis","","A small molecule inhibitor was investigated as a proof-of-concept strategy against hepatocellular carcinoma (HCC) and colorectal cancer (CRC) by targeting the GIT1–MAT2B interaction. Because no GIT1 crystal structure was available, a molecular model supported computer-based discovery and screening. Among nine compounds, compound 3 (C3) selectively engaged GIT1, reduced MAT2B binding, suppressed downstream cRAF/MEK/ERK signaling, induced apoptosis, and arrested the cell cycle, while limiting colony formation and migration. In mice, C3 was well tolerated and inhibited CRC growth and liver metastasis.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-small-molecule-inhibitor-of-arf-gtpase-protein-1-limits-liver-and-colon-cancer-cell-growth-and-metastasis/352497/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-small-molecule-inhibitor-of-arf-gtpase-protein-1-limits-liver-and-colon-cancer-cell-growth-and-metastasis/352497.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What cancer-related target does the study focus on?","Question",{"text":63,"@type":64},"The study focuses on ARF GTPase protein 1 (GIT1) and its interaction with methionine adenosyltransferase 2B (MAT2B), which supports signaling and tumorigenicity in HCC and CRC.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the small molecule (C3) discovered despite the absence of a GIT1 crystal structure?",{"text":68,"@type":64},"A molecular model was built for GIT1, enabling a computer-based drug discovery screening for compounds targeting the accessible ankyrin repeat domain near the MAT2B interaction site.",{"name":70,"@type":61,"acceptedAnswer":71},"What biological effects does compound 3 (C3) cause in liver and colon cancer cells?",{"text":72,"@type":64},"C3 inhibits proliferation, induces apoptosis, arrests the G2/M cell cycle, and reduces colony formation and migration while lowering MEK activity and cyclin D1 expression.",{"name":74,"@type":61,"acceptedAnswer":75},"What did the in vivo experiments show about C3?",{"text":76,"@type":64},"In immune-competent mice, C3 administration was well tolerated and inhibited murine CRC growth and liver metastasis; in nude mice, it inhibited human CRC growth in the livers.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},352497,1791439183,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nA small molecule inhibitor of ARF GTPase protein 1 limits liver and colon cancer cell growth and metastasis  \nHui Peng1,5, Jyoti Chhimwal 1,5, Wei Fan1, Jiaohong Wang 1, Lucía Barbier-Torres1, Sonal Sinha1, Avradip Chatterjee 2, Yi Zhang3, Maria Lauda Tomasi 1, José M. Mato 4, Ramachandran Murali2 and Shelly C. Lu 1 ✉  \n© The Author(s) 2026  \n\n| | ARF GTPase protein 1 (GIT1) is a scaffold protein that is overexpressed in hepatocellular carcinoma (HCC) and colorectal cancer (CRC) . GIT1 forms a complex with methionine adenosyltransferase 2B (MAT2B) that activates RAS-RAF-MEK-ERK signaling in HCCand CRC to enhance tumorigenicity. Here, we investigated in a proof-of-concept study whether a small molecule that disrupts GIT1-MAT2B interaction can be effective in HCC and CRC treatment. Since the GIT1 crystal structure is unavailable, we developed a molecular model and used computer-based drug discovery approach to screen for small molecules targeting the GIT1 ankyrin repeat domain, the region closest to where MAT2B interacts that is accessible. Of nine compounds tested, compound 3 (C3) selectively interacts with GIT1 and shows an anti-cancer effect in a GIT1-dependent manner. C3 is antiproliferative, induced apoptosis and G2/M cell cycle arrest while inhibiting colony formation and migration in liver and colon cancer cells. C3 lowered interaction between GIT1 and MAT2B, and with downstream effectors cRAF, MEK and ERK, lowering MEK activity and cyclin D1 expression. Unexpectedly, C3 stabilized GIT1 interaction with cyclin B1 while weakening cyclin B1’s interaction with components of the anaphase promoting complex, concomitant with sustained cyclin B1 expression and mitosis arrest. In mice, C3 administration was well tolerated and inhibited murine CRC growth and liver metastasis in immune competent mice and human CRC growth in the livers of nude mice. In conclusion, a small molecule inhibitor that disrupts GIT1’s normal interactome is a promising new | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | approach to treating liver and colon cancers. |  |\n|  |  |  |\n|  |  |  |\n|  | Cell Death and Disease (2026)17:238; [https://doi.org/10.1038/s41419-026-08477-8](https://doi.org/10.1038/s41419-026-08477-8) |  |\n|  |  |  |\n\nINTRODUCTION  \nLiver cancer is the fourth most common cause of cancer-related death and the second most lethal tumor with a 5-year survival of 18% [1] . Majority of hepatocellular carcinoma (HCC) patients present late and only 30% are candidates for surgical resection but still face a recurrence rate of about 50% at 3 years [2] . Colorectal cancer (CRC) is the second and third most common cancer diagnosed in women and men, respectively [3] . Approximately 35% of CRC patients present with metastatic colorectal cancer (mCRC) at time of diagnosis and up to 50% of patients with initially localized CRC develop mCRC later [4] . Much progress has been made in treating mCRC and advanced HCC, but the overall prognosis remains poor. Although traditional chemotherapies can prolong survival, they often have signiﬁcant adverse side effects [2] . Therefore, targeted treatment strategies using small molecule inhibitors are still highly sought after.  \nIn our search to characterize cellular pathways that are important for liver and colon cancer growth, we identiﬁed ARF GTPase protein 1 (GIT1), a scaffold protein, and methionine adenosyltransferase 2B (MAT2B) to be overexpressed in HCC and CRC [5, 6] . The human GIT1’s structure is composed of an amino-  \nterminal zinc ﬁnger-like motif, an ADP ribosylation factor (ARF) GTPase-activating protein (GAP) domain, three ankyrin (ANK) repeats, and a conserved carboxyl-terminal region that interacts with paxillin. GIT1 affects the function of both G protein-coupled receptors and tyrosine kinase-coupled receptors. Ac","cbCaiakmdCEsVNBT","https://ap.wps.com/l/cbCaiakmdCEsVNBT","pdf",6774485,13,"English","# Introduction\n# Target Identification and Rationale\n# Proof-of-Concept Strategy and Compound Screening\n# Cellular and Molecular Effects of Compound 3\n# In Vivo Efficacy and Safety\n# Conclusion","[{\"question\":\"What cancer-related target does the study focus on?\",\"answer\":\"The study focuses on ARF GTPase protein 1 (GIT1) and its interaction with methionine adenosyltransferase 2B (MAT2B), which supports signaling and tumorigenicity in HCC and CRC.\"},{\"question\":\"How was the small molecule (C3) discovered despite the absence of a GIT1 crystal structure?\",\"answer\":\"A molecular model was built for GIT1, enabling a computer-based drug discovery screening for compounds targeting the accessible ankyrin repeat domain near the MAT2B interaction site.\"},{\"question\":\"What biological effects does compound 3 (C3) cause in liver and colon cancer cells?\",\"answer\":\"C3 inhibits proliferation, induces apoptosis, arrests the G2/M cell cycle, and reduces colony formation and migration while lowering MEK activity and cyclin D1 expression.\"},{\"question\":\"What did the in vivo experiments show about C3?\",\"answer\":\"In immune-competent mice, C3 administration was well tolerated and inhibited murine CRC growth and liver metastasis; in nude mice, it inhibited human CRC growth in the livers.\"}]","A small molecule inhibitor of ARF GTPase protein 1 limits liver and colon cancer cell growth and metastasis | PDF",1790099971,33,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebbdacc125d4c1a923c8f5953e0fcf21.webp",983,1305,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a10417d41aee8f474cc216999a6c4ed8.webp",982,1304,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ab9dee3dfbf8b0171744205400ed911.webp",981,1303,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e4b38a7cdd5b7caf492c5a7a3840986.webp",980,1301]